Clinical Trial Update: A Study of Intravenous Mircera in Dialysis Patients With Chronic Renal Disease and Anemia. [Phase 3]

View source ↗

Summary

This document reports the completion and posting of results for a Phase 3 study evaluating intravenous Mircera for anemia in dialysis patients with chronic kidn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease

Drugs mentioned

• MIRCERA (METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Anemia | Phase 3 | Status: COMPLETED | Results posted: 2016-05-26